• Patients with Burkitt leukemia/lymphoma are treated with regimens specific for this diagnosis. (medscape.com)
  • Vincristine is delivered via intravenous infusion for use in various types of chemotherapy regimens. (wikipedia.org)
  • Therapy of lymphoblastic lymphoma (LL) has evolved with use of chemotherapy regimens modeled after those for acute lymphocytic leukemia (ALL). (ashpublications.org)
  • Administering time-limitedcombination regimens of venetoclax plus obinutuzumab or venetoclax plus obinutuzumab and ibrutinib was superior to chemoimmunotherapy in achieving undetectable measurable residual disease (MRD) in the peripheral blood at month 15 in fit patients with chronic lymphocytic. (ascopost.com)
  • Ibrutinib is associated with increased risk of bleeding compared to other chemotherapy regimens due to inhibition of BTK and TEC tyrosine kinase leading to decreased platelet activation. (fortuneonline.org)
  • FDA approved zanubrutinib (Brukinsa, BeiGene USA, Inc.) for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). (org.in)
  • The study includes patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL)/small lymphocytic lymphoma (SLL) and patients with Richter's Syndrome (RS). (researcherprofiles.org)
  • Its main uses are in non-Hodgkin's lymphoma as part of the chemotherapy regimen CHOP R-CVP, Hodgkin's lymphoma as part of MOPP, COPP, BEACOPP, or the less popular Stanford V chemotherapy regimen in acute lymphoblastic leukemia (ALL), and in treatment for nephroblastoma. (wikipedia.org)
  • The purpose of the study is to find out if an investigational drug called PRGN-3007 UltraCAR-T cells (PRGN-3007 T cells) can help people with ROR1-positive hematologic chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL) and solid tumor triple negative breast cancer (TNBC) malignancies. (moffitt.org)
  • This is a Phase I dose-finding study of FT819 as monotherapy and in combination with IL-2 in subjects with relapsed/refractory B-cell Lymphoma, Chronic Lymphocytic Leukemia and Precursor B-cell Acute Lymphoblastic Leukemia. (researcherprofiles.org)
  • This phase I trial studies the side effects and best dose of CD19/CD20 chimeric antigen receptor (CAR) T-cells when given together with chemotherapy, and to see how effective they are in treating patients with non-Hodgkin's B-cell lymphoma or chronic lymphocytic leukemia that has come back (recurrent) or has not responded to treatment (refractory). (researcherprofiles.org)
  • CD19 and CD20 are commonly found on non-Hodgkin?s B-cell lymphoma and chronic lymphocytic leukemia cells. (researcherprofiles.org)
  • Combining CD19/CD20 CAR-T cells and chemotherapy may help treat patients with recurrent or refractory B-cell lymphoma or chronic lymphocytic leukemia. (researcherprofiles.org)
  • One study reveals the benefits of reducing the number of cycles of chemotherapy for treating patients with diffuse large B-cell lymphoma. (hematology.org)
  • however, because lymphoblastic lymphoma and acute lymphoblastic leukemia (ALL) are known to represent the same disease entity, the World Health Organization (WHO) classification has unified these entities as precursor B-cell and T-cell lymphoblastic leukemia/lymphoma. (medscape.com)
  • Many investigators have suggested that both lymphoblastic lymphoma and acute lymphoblastic leukemia (ALL) may be part of one clinical spectrum of a single malignant lymphoproliferative disorder . (medscape.com)
  • Although several subtypes of T-cell lymphoblastic leukemia/lymphoma exist, early T-cell precursor lymphoblastic leukemia (ETP-ALL) is the only subtype recognized as an entity in the revised 2016 WHO tumor classification. (medscape.com)
  • [ 1 ] ETP-ALL frequently has mutations in RUNX1 and/or ETV6 in addition to genes that are more commonly associated with myeloid neoplasms and are otherwise rare in T-cell lymphoblastic leukemia/lymphoma (such as FLT3 , IDH1/2 , TET2 , and DNMT3A mutations). (medscape.com)
  • Non-ETP subtypes of T-cell lymphoblastic leukemia/lymphoma, in contrast, are associated with activating NOTCH1 mutations in over half of all patients and an additional 10% to 15% of cases have FBXW7 mutations, which also result in increased NOTCH signaling. (medscape.com)
  • T-lymphoblastic lymphoma (T-LBL) accounts for 25-30% of childhood NHL and is closely related to T-lymphoblastic leukemia (T-ALL). (medscape.com)
  • The estimated overall incidence of acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma in Europe is 1.28 per 100 000 individuals annually, with significant age-related variations (0.53 at 45-54 years, ∼1.0 at 55-74 years and 1.45 at 75-99 years). (medscape.com)
  • PURPOSE: This phase II trial is studying how well giving rituximab together with combination chemotherapy works in treating patients with stage II, stage III, or stage IV diffuse large B-cell non-Hodgkin's lymphoma. (survivornet.com)
  • Food and Drug Administration approved the combination of nivolumab (OPDIVO, Bristol-Myers Squibb Co.) plus ipilimumab (YERVOY, Bristol-Myers Squibb Co.) and 2 cycles of platinum-doublet chemotherapy as first-line treatment for patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genomic tumor aberrations. (blogspot.com)
  • As a single agent, PURINETHOL will induce complete remission in approximately 10% of pediatric patients and adults with acute myelogenous leukemia or its subclassifications. (druglib.com)
  • It is concluded a prevalence of leukemia in pediatric patients, with a predominance of the subtype Acute Lymphoblastic Leukemia (ALL). (sld.cu)
  • In a study reported in the Journal of Clinical Oncology, Elsayed et al developed a risk score based on single nucleotide polymorphisms (SNPs) associated with cytarabine pharmacodynamics or clinical outcomes that identified pediatric patients with acute myeloid leukemia (AML) who could benefit from. (ascopost.com)
  • In May 2019 FDA approved Ruxolitinib for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older. (org.in)
  • PURINETHOL is not effective in chronic lymphatic leukemia, the lymphomas (including Hodgkins Disease), or solid tumors. (druglib.com)
  • Methotrexate, a folic acid analog/antimetabolite, can be curative for women with choriocarcinoma and is also useful for non-Hodgkin lymphomas and acute lymphocytic leukemias (ALLs) in children. (medquizzes.net)
  • thus, tumors with a high cell turnover are most susceptible (certain leukemias and lymphomas, small proliferating tumors, "recruited" tumor cells, and micrometastases). (doctorlib.info)
  • Lymphoblastic leukemias/lymphomas are neoplasms of precursor T cells and B cells or lymphoblasts. (medscape.com)
  • It is used in the treatment of blood cancer (chronic myeloid leukaemia and Acute lymphocytic leukemia) and gastrointestinal stromal tumor. (hospitalsuppliers.co.in)
  • OBJECTIVES: I. Assess the feasibility and outcome of intensified induction/consolidation followed by intensified re-induction/re-intensification in infants less than 1 year of age with newly diagnosed acute lymphocytic leukemia (ALL). (knowcancer.com)
  • The treatment regimen for patients with ALL is determined primarily by the Philadelphia chromosome status of the leukemia and the age of the patient. (medscape.com)
  • Patients who have contraindication to the lymphodepletion chemotherapy regimen. (moffitt.org)
  • Post-surgery, the patient showed significant clinical improvement and was started on a chemotherapy regimen with complete remission at 1 year. (frontiersin.org)
  • Under the reduced regimen, chemotherapy lasts a total of 84 days, compared to 126 days with the six-cycle regimen. (hematology.org)
  • Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study. (cancercluster-salzburg.at)
  • It is also used to induce remission in ALL with dexamethasone and L-asparaginase, and in combination with prednisone to treat childhood leukemia. (wikipedia.org)
  • PURINETHOL (mercaptopurine) is indicated for remission induction and maintenance therapy of acute lymphatic leukemia. (druglib.com)
  • However, reliance upon PURINETHOL alone is not justified for initial remission induction of acute lymphatic leukemia since combination chemotherapy with vincristine, prednisone, and L-asparaginase results in more frequent complete remission induction than with PURINETHOL alone or in combination. (druglib.com)
  • The duration of complete remission induced in acute lymphatic leukemia is so brief without the use of maintenance therapy that some form of drug therapy is considered essential. (druglib.com)
  • On protocol Total XII, 182 children achieved remission and received weekly methotrexate 40 mg/m 2 parenterally and daily oral 6MP, interrupted every 6 weeks during the first year by pulse chemotherapy. (ashpublications.org)
  • Addition of ponatinib led to a higher rate of MRD-negative complete remission vs imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia. (targetedonc.com)
  • During the Society of Hematologic Oncology 2023 Annual Meeting, results from the phase 3 PhALLCON trial (NCT03589326) indicated that incorporating the tyrosine kinase inhibitor (TKI) ponatinib (Iclusig) into reduced-intensity chemotherapy resulted in a higher minimal residual disease (MRD)-negative complete remission (CR) rate at the end of induction in patients with Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) vs imatinib (Gleevec). (targetedonc.com)
  • It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. (lookformedical.com)
  • Remission maintenance treatment options in chronic lymphocytic leukemia. (cancercluster-salzburg.at)
  • Adult patients with Chronic Lymphocytic Leukemia (CLL) ( 1.2 ). (drugs.com)
  • A second study compares several drug combinations for treating older patients with chronic lymphocytic leukemia. (hematology.org)
  • Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia. (cancercluster-salzburg.at)
  • Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99. (druglib.com)
  • Also, see the Childhood Acute Lymphoblastic Leukemia: Diagnosis, Management, and Complications slideshow to help recognize and treat this disease and its associated complications. (medscape.com)
  • Scientists at St. Jude Children's Research Hospital are studying the impact of genetic ancestry on childhood acute lymphoblastic leukemia (ALL). (ascopost.com)
  • 6-Mercaptopurine (6MP) and methotrexate are the backbone of continuation therapy for childhood acute lymphoblastic leukemia (ALL). (ashpublications.org)
  • T HE "BACKBONE" of continuation chemotherapy for childhood acute lymphoblastic leukemia (ALL) protocols comprises oral daily 6-mercaptopurine (6MP) and weekly methotrexate (MTX). (ashpublications.org)
  • It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. (lookformedical.com)
  • Population-based attributes for Social Exclusion Index (SEI) and household size may be useful surrogate markers of early exposure to childhood infections, which has been found to decrease the risk of acute lymphoblastic leukemia (ALL). (medscape.com)
  • The response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient (pediatric patient or adult). (druglib.com)
  • This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients with Acute Myelogenous Leukemia (AML) or high risk Myelodysplastic Syndrome (MDS). (rochester.edu)
  • FDA approved quizartinib (Vanflyta, Daiichi Sankyo, Inc.) with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication (ITD)-positive, as detected by an FDA-approved test. (org.in)
  • FDA approved olutasidenib (Rezlidhia) capsules for adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test. (org.in)
  • One medication that has been hypothesized to precipitate manic episodes is the chemotherapy agent methotrexate. (psychiatrictimes.com)
  • This case report demonstrates the acute onset of mania in a patient with no history of bipolar disorder , which putatively was precipitated by the use of intrathecal methotrexate in the treatment of acute lymphoblastic leukemia. (psychiatrictimes.com)
  • He completed a course of prednisone treatment and received a second dose of intrathecal methotrexate (IT MTX) a few days prior to presentation. (psychiatrictimes.com)
  • Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia. (druglib.com)
  • PURPOSE To describe event-free survival (EFS) and toxicities in children with low-risk acute lymphoblastic leukemia (ALL) assigned to receive either continuous 6-mercaptopurine (6-MP) and weekly methotrexate (MTX) or intermittent 6-MP with intermediate-dose MTX, as maintenance treatment. (druglib.com)
  • The Children's Cancer Group 1952 (CCG-1952) clinical trial studied the substitution of oral 6-thioguanine (TG) for 6-mercaptopurine (MP) and triple intrathecal therapy (ITT) for intrathecal methotrexate (IT-MTX) in the treatment of standard-risk acute lymphoblastic leukemia. (druglib.com)
  • In the phase II SWOG 1318 trial reported in the Journal of Clinical Oncology, Advani et al found that blinatumomab induction and consolidation followed by maintenance with POMP (prednisone, vincristine, mercaptopurine, and methotrexate) produced good outcomes in patients aged ≥ 65 years with newly. (ascopost.com)
  • Methotrexate-induced lung disease, including acute or chronic interstitial pneumonitis, is a potentially dangerous lesion, which may occur acutely at any time during therapy and has been reported at low doses. (nih.gov)
  • Role of signal transduction inhibition in treatment of acute myelogenous leukemia/myelodysplasia. (rochester.edu)
  • Historically, acute promyelocytic leukemia (APL) was considered to be one of the most fatal forms of acute leukemia with poor outcomes before the introduction of the vitamin A derivative all- trans retinoic acid (ATRA). (nature.com)
  • Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML), with the first description as a distinct entity in 1957. (nature.com)
  • Induction consolidation was administered with 8 or 9 alternating cycles of chemotherapy over 5 to 6 months with intrathecal chemotherapy prophylaxis, followed by maintenance therapy. (ashpublications.org)
  • Combination Systemic Chemotherapy plus 3-Drug Combination Intrathecal Chemotherapy. (knowcancer.com)
  • Systemic Chemotherapy plus Single-Agent Intrathecal Chemotherapy. (knowcancer.com)
  • 4-Drug Combination Systemic Chemotherapy plus Single-Agent Intrathecal Chemotherapy. (knowcancer.com)
  • Chemotherapy continues to be a typical treatment for many cancers. (turningthetideovarianretreat.com)
  • Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing more than a quarter of all pediatric cancers. (medscape.com)
  • See Chronic Leukemias: 4 Cancers to Differentiate , a Critical Images slideshow, to help detect chronic leukemias and determine the specific type present. (medscape.com)
  • Overview of Leukemia Leukemias are cancers of white blood cells or of cells that develop into white blood cells. (msdmanuals.com)
  • Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. (druglib.com)
  • The objective of this research was to synthesize studies that characterize the clinical and epidemiological profile of patients with leukemia, the types of treatments used, duration and outcomes for the cases. (sld.cu)
  • Leukemia Society of America, Clinical Scholar Award. (rochester.edu)
  • In chronic lymphocytic leukemia the balance between the pro-apoptotic and anti-apoptotic members of the bcl-2 family is involved in the pathogenesis, chemorefractoriness and clinical outcome. (haematologica.org)
  • A phase 3 study shows Mylotarg (gemtuzumab ozogamicin), when given with standard chemotherapy, decreased the risk of relapse, especially in patients who later undergo a transplantation. (curetoday.com)
  • Patients in the study were given standard chemotherapy with or without Mylotarg. (curetoday.com)
  • The purpose of this study is to compare any good and bad effects the study drug atezolizumab has on the cancer when combined with the standard chemotherapy drugs gemcitabine and cisplatin (or GC) in two different dosing schedules: chemotherapy (GC) before atezolizumab vs. GC after atezolizumab. (bcan.org)
  • Nonetheless, today, most patients with BL can be cured with intensive conventional chemotherapy by accepting the fact that some will be over-treated, but directing research towards trying to identify such patients and minimizing therapy to the extent possible. (hindawi.com)
  • In patients with newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation who were ineligible for intensive chemotherapy, the addition of the IDH1 inhibitor ivosidenib to azacitidine significantly improved survival vs azacitidine alone, according to data presented at the 2021 American. (ascopost.com)
  • However, the specific association of leukemias and other hematologic neoplasms with mediastinal nonseminomatous germ cell tumors, rather than with all germ cell tumors, remains unexplained. (health.am)
  • An 85-year-old Caucasian male with active comorbidities of hypertension, hyperlipidemia, stage 3c chronic kidney disease, had a diagnosis of chronic lymphocytic leukemia (CLL) Rai stage I with symptomatic diffuse adenopathy. (fortuneonline.org)
  • Leukemia is a group of clonal diseases derived from a single cell with a genetic alteration in bone marrow or peripheral lymphoid tissue, and each type is determined by the specificity of the source cell. (sld.cu)
  • There was a significant improvement in survival of Acute Myeloid Leukemia, Chronic Lymphoid leukemia, CML and ALL, the latter approximately with 90% cure rate in children. (sld.cu)
  • Preseptal cellulitis can increase of lymphoid neoplasia of chemotherapy in a link. (underwoodaccounting.com)
  • After being evaluated by the psychiatric consult liaison (C-L) team, Charlie was started on olanzapine, which was titrated to 10 mg BID for treatment of acute manic and psychotic symptoms. (psychiatrictimes.com)
  • These results are inferior to those achieved with combination chemotherapy employing optimum treatment schedules. (druglib.com)
  • PURINETHOL is not effective for prophylaxis or treatment of central nervous system leukemia. (druglib.com)
  • Criteria relevant to hematology patient populations specifically include immunosuppressive disease or immunosuppressive treatment (thus post-allogeneic transplantation, active or recent chemotherapy or immunotherapy, active malignancy) or sickle cell anemia, in patients unlikely to respond optimally to vaccination, or in those not fully vaccinated. (hematology.org)
  • As the therapy is used, each leukemia subtype had its peculiarities regarding the treatment, especially the introduction of imatinib for chronic myeloid leukemia (CML) and prophylactic cranial irradiation for cases of ALL. (sld.cu)
  • Chronic leukemia showed higher treatment duration. (sld.cu)
  • Fludara is a type of chemotherapy and is the first of a new class of drugs (purine analogs) active in the treatment of CLL. (broomeoncology.com)
  • Rb, prednisone for patch-stage and the 2016 revision was of treatment is much chemo drugs to baseline pre-pet scan in united kingdom. (underwoodaccounting.com)
  • Patients with low-risk disease or those with intermediate-risk AML without a matched family donor had additional treatment that included chemotherapy with or without Mylotarg. (curetoday.com)
  • After a median of 65.4 months following treatment with Venclexta plus Gazyva, results confirm the combination continues to be an effective fixed-duration and chemotherapy-free option for patients with previously untreated CLL and coexisting conditions. (biospace.com)
  • After eight years of follow-up in people with previously untreated FL, a meaningful improvement in PFS was maintained with Gazyva plus chemotherapy, confirming its role as a standard of care for first-line treatment. (biospace.com)
  • Ibrutinib is an irreversible inhibitor of Bruton tyrosine kinase (BTK) which is FDA approved for treatment of chronic lymphocytic leukemia (CLL) and multiple other B-cell lymphoproliferative disorders. (fortuneonline.org)
  • Abirapro is a hormonal treatment not a chemotherapy drug. (hospitalsuppliers.co.in)
  • A new study suggests the standard course of treatment for younger patients with low-risk DLBCL can safely be reduced by two cycles of chemotherapy. (hematology.org)
  • Three years after receiving treatment, 99 percent of those receiving four cycles of chemotherapy and 98 percent of those receiving six cycles remained alive. (hematology.org)
  • It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (lookformedical.com)
  • This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others. (wikipedia.org)
  • TRANSPLANTATION: 2-Drug Combination Myeloablative Chemotherapy followed by Radiotherapy followed by Hematopoietic Rescue plus GVHD Prophylaxis. (knowcancer.com)
  • Children who develop acute myeloid leukemia (AML) are typically treated with chemotherapy, but more than half of patients eventually relapse and go on to transplantation or second-line therapy. (curetoday.com)
  • Patients with Philadelphia chromosome-positive (Ph+) ALL receive a tyrosine kinase inhibitor (TKI) in combination with chemotherapy. (medscape.com)
  • Food and Drug Administration granted accelerated approval to rucaparib (RUBRACA, Clovis Oncology, Inc.) for patients with deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. (blogspot.com)
  • Vincristine, also known as leurocristine and marketed under the brand name Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. (wikipedia.org)
  • Prior chemotherapy or immunotherapy for metastatic urothelial cancer. (bcan.org)
  • however, the most prevalent forms of human cancer respond poorly or not at all to chemotherapy. (doctorlib.info)
  • Today, TKIs and chemotherapy or steroids are the standard of care in Ph-positive ALL," Elias Jabbour, MD, a professor in the Department of Leukemia, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center in Houston, said during the presentation. (targetedonc.com)
  • The trial, which tracked patients for a median of more than five years and up to 11 years, showed four cycles of chemotherapy is as effective as six cycles in terms of eradicating cancer and preventing relapse. (hematology.org)
  • Antimetabolites that are useful in cancer chemotherapy. (lookformedical.com)
  • Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. (survivornet.com)
  • Giving rituximab together with combination chemotherapy may kill more cancer cells. (survivornet.com)
  • Researchers said the ability to reduce chemotherapy cycles by one-third is likely to come as welcome news for patients, who often must put their lives on hold as they cope with the side effects of chemotherapy. (hematology.org)
  • Our study shows you can spare two cycles of chemotherapy and it is equally effective. (hematology.org)
  • In addition, the data suggest that reducing the number of chemotherapy cycles also reduces the number of adverse events by one-third. (hematology.org)
  • Altogether, 1,295 adverse events occurred in the 295 patients who underwent six cycles of chemotherapy compared with 835 adverse events in the 293 patients who received just four cycles of chemotherapy. (hematology.org)
  • The researchers will continue to track the health of study participants for an additional five years to determine whether decreasing the number of chemotherapy cycles may help reduce long-term side effects of chemotherapy. (hematology.org)
  • The patient was managed conservatively with intravenous hydration for his acute renal failure, blood transfusions and pain medications. (fortuneonline.org)
  • The approval was based on data from REACH1 trail 7 , phase 2, an open-label, single-arm, multicenter study of Ruxolitinib in combination with corticosteroids in patients with steroid-refractory grade II-IV acute GVHD. (org.in)
  • She continued therapy at home (prednisone, allopurinol). (wikilectures.eu)
  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a rituximab product in combination with chemotherapy, as single-agent maintenance therapy. (drugs.com)
  • 15 mg of prednisone daily or equivalent), or patients who have received any other form of immunosuppressive therapy within 7 days prior to leukapheresis. (moffitt.org)
  • In the past two decades, therapy for newly diagnosed APL has evolved from an all- trans retinoic acid (ATRA)+chemotherapy backbone for all patients to the addition of arsenic trioxide (ATO) to ATRA with omission of chemotherapy in low-risk patients as a new standard of care. (nature.com)
  • These patients usually can't tolerate aggressive chemotherapy, so the CLL11 study compared Leukeran (chlorambucil), an older chemotherapy, against Leukeran with Rituxan (rituximab), a current standard of care, or Leukeran with Gazyva (obinutuzumab), a recently approved therapy for newly diagnosed CLL. (curetoday.com)
  • This is a very different approach from that taken by pioneer chemotherapists in Africa, where it was felt that the host response provided an important part of therapy, and too much chemotherapy could, by abrogating immunological defences against the tumor, lead to a negative result. (hindawi.com)
  • A woman with human immunodeficiency virus (HIV) who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months, despite cessation of antiretroviral therapy, according to research presented at the Conference on Retroviruses and. (ascopost.com)
  • However, increasing intensity of therapy such that neutropenia precludes chemotherapy administration may be counterproductive. (ashpublications.org)
  • My principle research interests are in the prevention and therapy of graft-versus-host disease (GVHD) and in the use of graft-versus-leukemia to eradicate blood disorders. (harvard.edu)
  • The drug is used in the therapy of acute leukemia. (lookformedical.com)
  • In previous studies of chronic lymphocytic leukemia (CLL), patients who were relatively healthy were often enrolled over older, sicker patients, despite the fact that the majority of patients with CLL are more than 65 years old and often have other health issues (comorbidities). (curetoday.com)
  • Patients were randomly assigned 2:1 to reduced-intensity chemotherapy in combination with ponatinib 30 mg once daily with dose reduction to 15 mg once daily (n = 164) after MRD-negative CR in the induction phase or reduced intensity chemotherapy with imatinib at a starting dose of 600 mg once daily (n = 81). (targetedonc.com)
  • The disease is now considered to be the most curable subtype of acute myeloid leukemia (AML) in adults. (nature.com)
  • Eligible patients needed to have an ECOG performance status of 2 or less, no history or current diagnosis of chronic, accelerated, or blastic phase chronic myeloid leukemia, and an absence of clinically significant of uncontrolled cardiovascular disease. (targetedonc.com)
  • With a shorter duration of chemotherapy, patients are back to daily life with their families and back to work more quickly," said lead study author Viola Poeschel, MD, of Saarland University Medical School in Homburg/Saar, Germany. (hematology.org)
  • Chemotherapy-induced peripheral neuropathy can be severe, and may be a reason to reduce or avoid using vincristine. (wikipedia.org)
  • Prior allogeneic hematopoietic stem cell transplant (HSCT) or donor lymphocyte infusion within 6 months prior to enrollment, current acute graft versus host disease grade 2-4 by Glucksberg criteria or severity B-D by by International Bone Marrow Transplant Registry (IBMTR) index or history of severe (grade 3-4) acute graft versus host disease. (moffitt.org)
  • Timeline of disease course, treatments, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) tests, antibody tests, and Vero E6 cell line culture from day 0 to day 240. (ajtmh.org)